July 5, 2025 • 3 mins
Welcome to Ozempic Weightloss Unlocked, your source for the latest news, science, and lived experiences around Ozempic – and how it’s transforming the landscape of weight management and health.
Semaglutide, the active ingredient in Ozempic, began as a treatment for type two diabetes but quickly made waves for its powerful effect on weight loss. According to Yale University, Ozempic works by slowing stomach emptying and interacting with the brain’s appetite regulation centers, naturally decreasing hunger and helping you feel fuller longer. Major clinical trials, as reported by the New England Journal of Medicine, found that people using Ozempic lost on average fifteen percent of their body weight over a sixty-eight-week period. That’s a significant shift in the fight against obesity and has inspired a wave of success stories in 2025.
Take Maria, a forty-two-year-old mother of two who, after years of struggling with different diets, lost thirty-five pounds in six months after her doctor prescribed Ozempic. She combined her medication with healthy foods and daily walks, gaining more energy and renewed self-confidence. John, a long-time executive living with type two diabetes, lost forty pounds and enjoyed not only improved blood sugar but the feeling of having his life back. Their stories, shared on Yale’s health campus, point to the idea that consistency, a holistic approach, and strong support from healthcare professionals and family make all the difference.
Ozempic doesn’t just bring physical changes. Dr. Daniel Drucker, who helped develop GLP-1 medicines like Ozempic, told Toronto Life that the drug’s success has helped validate obesity as a biological, not just behavioral, condition. For many, it’s become proof that medical science can help overcome a complex health challenge – not just willpower alone.
Globally, Ozempic and its sister drug, Wegovy, are reshaping national health systems like the NHS in the United Kingdom. NHS reports show over three million prescriptions for Ozempic issued annually, a testament to its popularity and potential. Wegovy, which is a higher-dose version designed specifically for weight loss, became available through specialist services in 2024. Healthcare leaders stress, however, that medications like Ozempic should support, not replace, good nutrition and regular activity. A combined approach delivers the best outcomes, and ongoing monitoring is essential to managing both progress and any possible side effects.
Speaking of side effects, most users report mild-to-moderate gastrointestinal issues, especially at the start. There are still open questions about the long-term risks, and health authorities caution against unlicensed or cosmetic providers offering Ozempic outside proper medical supervision.
In the competitive field of weight loss drugs, new challengers are emerging. According to Drugs.com and recent publications in JAMA Internal Medicine, Mounjaro, which combines GLP-1 and another gut hormone, has shown even greater weight loss than Ozempic in large studies. Nearly eighty-two percent of people using Mounjaro lost at least five percent of their body weight, compared to about sixty-seven percent for Ozempic. There’s also a promising newcomer: a once-monthly shot called MariTide, which recent phase two trials show may rival or even exceed Ozempic’s results, though it is not yet widely available.
Looking ahead, Ozempic and its competitors are not just for type two diabetes or general obesity. A June 2025 study reported by Live Science found Ozempic’s active ingredient may even help people with type one diabetes manage blood sugar and lose weight, hinting at a broader impact on medicine in the years to come.
That wraps up this episode of Ozempic Weightloss Unlocked. Thank you for tuning in and remember to subscribe so you never miss an update. This has been a Quiet Please production, for more check out quietplease dot ai.
Some great Deals https://amzn.to/49SJ3Qs
For more check out http://www.quietplease.ai
Semaglutide, the active ingredient in Ozempic, began as a treatment for type two diabetes but quickly made waves for its powerful effect on weight loss. According to Yale University, Ozempic works by slowing stomach emptying and interacting with the brain’s appetite regulation centers, naturally decreasing hunger and helping you feel fuller longer. Major clinical trials, as reported by the New England Journal of Medicine, found that people using Ozempic lost on average fifteen percent of their body weight over a sixty-eight-week period. That’s a significant shift in the fight against obesity and has inspired a wave of success stories in 2025.
Take Maria, a forty-two-year-old mother of two who, after years of struggling with different diets, lost thirty-five pounds in six months after her doctor prescribed Ozempic. She combined her medication with healthy foods and daily walks, gaining more energy and renewed self-confidence. John, a long-time executive living with type two diabetes, lost forty pounds and enjoyed not only improved blood sugar but the feeling of having his life back. Their stories, shared on Yale’s health campus, point to the idea that consistency, a holistic approach, and strong support from healthcare professionals and family make all the difference.
Ozempic doesn’t just bring physical changes. Dr. Daniel Drucker, who helped develop GLP-1 medicines like Ozempic, told Toronto Life that the drug’s success has helped validate obesity as a biological, not just behavioral, condition. For many, it’s become proof that medical science can help overcome a complex health challenge – not just willpower alone.
Globally, Ozempic and its sister drug, Wegovy, are reshaping national health systems like the NHS in the United Kingdom. NHS reports show over three million prescriptions for Ozempic issued annually, a testament to its popularity and potential. Wegovy, which is a higher-dose version designed specifically for weight loss, became available through specialist services in 2024. Healthcare leaders stress, however, that medications like Ozempic should support, not replace, good nutrition and regular activity. A combined approach delivers the best outcomes, and ongoing monitoring is essential to managing both progress and any possible side effects.
Speaking of side effects, most users report mild-to-moderate gastrointestinal issues, especially at the start. There are still open questions about the long-term risks, and health authorities caution against unlicensed or cosmetic providers offering Ozempic outside proper medical supervision.
In the competitive field of weight loss drugs, new challengers are emerging. According to Drugs.com and recent publications in JAMA Internal Medicine, Mounjaro, which combines GLP-1 and another gut hormone, has shown even greater weight loss than Ozempic in large studies. Nearly eighty-two percent of people using Mounjaro lost at least five percent of their body weight, compared to about sixty-seven percent for Ozempic. There’s also a promising newcomer: a once-monthly shot called MariTide, which recent phase two trials show may rival or even exceed Ozempic’s results, though it is not yet widely available.
Looking ahead, Ozempic and its competitors are not just for type two diabetes or general obesity. A June 2025 study reported by Live Science found Ozempic’s active ingredient may even help people with type one diabetes manage blood sugar and lose weight, hinting at a broader impact on medicine in the years to come.
That wraps up this episode of Ozempic Weightloss Unlocked. Thank you for tuning in and remember to subscribe so you never miss an update. This has been a Quiet Please production, for more check out quietplease dot ai.
Some great Deals https://amzn.to/49SJ3Qs
For more check out http://www.quietplease.ai
Mark as Played
Transcript
Episode Transcript
Available transcripts are automatically generated. Complete accuracy is not guaranteed.
Speaker 1 (00:00):
Welcome to Ozempic weight Loss Unlocked, your source for the
latest news, science, and lived experiences around ozempic and how
it's transforming the landscape of weight management and health. Semmaglutide,
the active ingredient in ozempic, began as a treatment for
type two diabetes, but quickly made waves for its powerful
effect on weight loss. According to Yale University, ozempic works
(00:23):
by slowing stomach emptying and interacting with the brain's appetite
regulation centres, naturally decreasing hunger and helping you feel fuller longer.
Major clinical trials, as reported by the New England Journal
of Medicine, found that people using ozempic lost on average
fifteen percent of their body weight over a sixty eight
week period. That's a significant shift in the fight against
(00:44):
obesity and has inspired a wave of success stories in
twenty twenty five. Take Maria, a forty two year old
mother of two who, after years of struggling with different diets,
lost thirty five pounds in six months after her doctor
prescribed ozempic. She combined find her medication with healthy foods
and daily walks, gaining more energy and renewed self confidence.
(01:05):
John A. Longtime executive living with type two diabetes, lost
forty pounds and enjoyed not only improve blood sugar, but
the feeling of having his life back. Their stories, shared
on Yale's Health campus, point to the idea that consistency,
a holistic approach, and strong support from healthcare professionals and
family make all the difference. Ozempic doesn't just bring physical changes.
(01:29):
Doctor Daniel Drucker, who helped develop GLP one medicines like ozepic,
told Toronto Life that the drug's success has helped validate
obesity as a biological, not just behavior or condition. For many,
it's become proof that medical science can help overcome a
complex health challenge, not just willpower alone. Globally, ozempic and
(01:50):
its sister drug wagovi are reshaping national health systems like
the NHS. In the United Kingdom. NHS reports show over
three million prescriptions for ozempic issue annually, a testament to
its popularity and potential. Where Govi, which is a higher
dose version designed specifically for weight loss, became available through
specialist services in twenty twenty four. Health care leaders stress, however,
(02:13):
that medications like ozepic should support, not replace, good nutrition,
and regular activity. A combined approach delivers the best outcomes.
An ongoing monitoring is essential to managing both progress and
any possible side effects. Speaking of side effects, most users
report mild to moderate gastrointestinal issues, especially at the start.
(02:35):
There are still open questions about the long term risks,
and health authorities caution against unlicensed or cosmetic providers offering
ozepic outside proper medical supervision. In the competitive field of
weight loss drugs, new challenges are emerging. According to drugs
dot Com and recent publications in Jarma Internal medicine, Munjaro,
(02:56):
which combines GLP one and another gut hormone, has shown
even greater weight loss than ozepic in large studies. Merely
eighty two percent of people using Munjaro must at least
five percent of their body weight, compared to about sixty
seven percent for Ozeenpic. There's also a promising newcomer, a
once monthly shot called Maritide, which recent phase two trials
(03:16):
show may rival or even exceed Ozepic's results, though it
is not yet widely available. Looking ahead, Ozepic and its
competitors are not just for type two diabetes or general obesity.
A June twenty twenty five, study reported by Lives Science
found ozempic's active ingredient may even help people with type
one diabetes manage blood sugar and lose weight, hinting at
(03:38):
a broader impact on medicine in the years to come.
That wraps up this episode of Ozepic Weight Loss Unlocked.
Thank you for tuning in and remember to subscribe so
you never miss an update. This has been a quiet
please production. For more check out Quiet Please dot ai
Welcome to Ozempic weight Loss Unlocked, your source for the
latest news, science, and lived experiences around ozempic and how
it's transforming the landscape of weight management and health. Semmaglutide,
the active ingredient in ozempic, began as a treatment for
type two diabetes, but quickly made waves for its powerful
effect on weight loss. According to Yale University, ozempic works
(00:23):
by slowing stomach emptying and interacting with the brain's appetite
regulation centres, naturally decreasing hunger and helping you feel fuller longer.
Major clinical trials, as reported by the New England Journal
of Medicine, found that people using ozempic lost on average
fifteen percent of their body weight over a sixty eight
week period. That's a significant shift in the fight against
(00:44):
obesity and has inspired a wave of success stories in
twenty twenty five. Take Maria, a forty two year old
mother of two who, after years of struggling with different diets,
lost thirty five pounds in six months after her doctor
prescribed ozempic. She combined find her medication with healthy foods
and daily walks, gaining more energy and renewed self confidence.
(01:05):
John A. Longtime executive living with type two diabetes, lost
forty pounds and enjoyed not only improve blood sugar, but
the feeling of having his life back. Their stories, shared
on Yale's Health campus, point to the idea that consistency,
a holistic approach, and strong support from healthcare professionals and
family make all the difference. Ozempic doesn't just bring physical changes.
(01:29):
Doctor Daniel Drucker, who helped develop GLP one medicines like ozepic,
told Toronto Life that the drug's success has helped validate
obesity as a biological, not just behavior or condition. For many,
it's become proof that medical science can help overcome a
complex health challenge, not just willpower alone. Globally, ozempic and
(01:50):
its sister drug wagovi are reshaping national health systems like
the NHS. In the United Kingdom. NHS reports show over
three million prescriptions for ozempic issue annually, a testament to
its popularity and potential. Where Govi, which is a higher
dose version designed specifically for weight loss, became available through
specialist services in twenty twenty four. Health care leaders stress, however,
(02:13):
that medications like ozepic should support, not replace, good nutrition,
and regular activity. A combined approach delivers the best outcomes.
An ongoing monitoring is essential to managing both progress and
any possible side effects. Speaking of side effects, most users
report mild to moderate gastrointestinal issues, especially at the start.
(02:35):
There are still open questions about the long term risks,
and health authorities caution against unlicensed or cosmetic providers offering
ozepic outside proper medical supervision. In the competitive field of
weight loss drugs, new challenges are emerging. According to drugs
dot Com and recent publications in Jarma Internal medicine, Munjaro,
(02:56):
which combines GLP one and another gut hormone, has shown
even greater weight loss than ozepic in large studies. Merely
eighty two percent of people using Munjaro must at least
five percent of their body weight, compared to about sixty
seven percent for Ozeenpic. There's also a promising newcomer, a
once monthly shot called Maritide, which recent phase two trials
(03:16):
show may rival or even exceed Ozepic's results, though it
is not yet widely available. Looking ahead, Ozepic and its
competitors are not just for type two diabetes or general obesity.
A June twenty twenty five, study reported by Lives Science
found ozempic's active ingredient may even help people with type
one diabetes manage blood sugar and lose weight, hinting at
(03:38):
a broader impact on medicine in the years to come.
That wraps up this episode of Ozepic Weight Loss Unlocked.
Thank you for tuning in and remember to subscribe so
you never miss an update. This has been a quiet
please production. For more check out Quiet Please dot ai
Popular Podcasts
NFL Daily with Gregg Rosenthal
Gregg Rosenthal and a rotating crew of elite NFL Media co-hosts, including Patrick Claybon, Colleen Wolfe, Steve Wyche, Nick Shook and Jourdan Rodrigue of The Athletic get you caught up daily on all the NFL news and analysis you need to be smarter and funnier than your friends.
On Purpose with Jay Shetty
I’m Jay Shetty host of On Purpose the worlds #1 Mental Health podcast and I’m so grateful you found us. I started this podcast 5 years ago to invite you into conversations and workshops that are designed to help make you happier, healthier and more healed. I believe that when you (yes you) feel seen, heard and understood you’re able to deal with relationship struggles, work challenges and life’s ups and downs with more ease and grace. I interview experts, celebrities, thought leaders and athletes so that we can grow our mindset, build better habits and uncover a side of them we’ve never seen before. New episodes every Monday and Friday. Your support means the world to me and I don’t take it for granted — click the follow button and leave a review to help us spread the love with On Purpose. I can’t wait for you to listen to your first or 500th episode!
Dateline NBC
Current and classic episodes, featuring compelling true-crime mysteries, powerful documentaries and in-depth investigations. Follow now to get the latest episodes of Dateline NBC completely free, or subscribe to Dateline Premium for ad-free listening and exclusive bonus content: DatelinePremium.com